Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Exploring treatments for Gulf War Illness-related gastrointestinal symptoms

Official title: Mechanisms of Gulf War Illness

Run by VA Office of Research and Development · NCT05972291 · Data updated 2026-11-12

This study is testing if taking glutamine can help veterans with Gulf War Illness feel better by easing their stomach problems like pain and diarrhea.

More Irritable Bowel Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment80 (estimated)
SponsorVA Office of Research and Development
Federal
Drugs / interventionschemotherapy
Locations1 site (Memphis, Tennessee)
StatusRecruiting
StartedOctober 16, 2023
Main results expectedJuly 30, 2027
Study endsSeptember 30, 2027
Registry record updatedAugust 19, 2026
Trial IDNCT05972291 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are veterans aged 18-65 with Gulf War Illness and chronic gastrointestinal symptoms that began during their deployment.

Probably not a fit

Patients with a history of inflammatory bowel disease, lactose intolerance, or other specified gastrointestinal conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the chronic gastrointestinal symptoms experienced by veterans with Gulf War Illness, focusing on the potential benefits of oral glutamine supplementation. The research aims to understand the mechanisms behind these symptoms, which include abdominal pain, diarrhea, and bloating, and how glutamine may restore intestinal permeability. By conducting this trial, the investigators hope to provide a novel treatment option for veterans suffering from these debilitating symptoms, which currently lack effective therapies. The study will involve veterans aged 18-65 who meet specific eligibility criteria related to their gastrointestinal health.

Why it matters

Potential benefit: If successful, this study could provide a new treatment option for veterans suffering from chronic gastrointestinal symptoms related to Gulf War Illness.

How similar studies have gone: Previous studies have shown promising results with glutamine supplementation in similar gastrointestinal conditions, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Veterans 18-65 years old with GWI and chronic GI symptoms (abdominal pain, diarrhea, bloating) that started during their deployment in the Persian Gulf
2. Veterans 18-65 years old with GWI and chronic GI symptoms (abdominal pain, diarrhea, bloating)
3. increased intestinal permeability on the lactulose/mannitol permeability test (ratio \>0.07)
4. able and willing to cooperate with the study

Exclusion Criteria:

1. current participation in another research protocol or unable to give informed consent
2. women with a positive urine pregnancy test or breastfeeding
3. history of inflammatory bowel disease, lactose intolerance and/or celiac sprue
4. \+ hydrogen breath test for bacterial overgrowth
5. \+ anti-endomysial antibody titer
6. use of NSAIDs 2 weeks before or during the study
7. known allergy to glutamine or whey protein
8. abdominal surgery except for removal of gallbladder, uterus, or appendix \>6 months prior to entry into the study
9. Abnormal serum BUN and/or creatinine
10. Mannitol recovery out of the normal range of 5-25 U/g
11. history of kidney disease
12. allergies to monosodium glutamate
13. current use of anti-seizure medications

Where it's running

  • Memphis VA Medical Center, Memphis, TN
    Memphis, Tennessee, United States
    Recruiting

Study contacts

  • Principal investigator: QiQi Zhou, MD PhD — Memphis VA Medical Center, Memphis, TN
  • Study coordinator: George N Verne
  • Email: George.Verne@va.gov
  • Phone: (901) 523-8990

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.